Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest news about Divis Laboratories aggregated by PharmaCompass.com.

    Client Virtual Booth

    DIVIS LABORATORIES

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Divis Laboratories
    india-flag Flag
    Country
    Country
    India
    Address
    Address
    Divis Laboratories LimitedDivi Towers, 7-1-77/E/1/303,Dharam Karan Road, Ameerpet,HYDERABAD - 500 016.Andhra Pradesh, India.
    Telephone
    Telephone
    91 402 378 6322
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.divislabs.com/
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Britannia most-loved, Divi’s Labs shunned by analysts in November
    Britannia most-loved, Divi’s Labs shunned by analysts in November

    https://www.moneycontrol.com/news/business/britannia-most-loved-divis-labs-shunned-by-analysts-in-november-9633531.html

    Shailaja Mohapatra MONEYCONTROL
    02 Dec 2022
    Share Share
    Divi's Lab falls over 1%, brokerages express concerns over growth sustainability
    Divi's Lab falls over 1%, brokerages express concerns over growth sustainability

    https://www.cnbctv18.com/market/stocks/divis-lab-falls-over-1-as-brokerages-express-concerns-over-growth-sustainability-12482732.htm

    CNBCTV18
    14 Feb 2022
    Share Share
    Divi's Labs tumbles more than 8% after Q2 numbers
    Divi's Labs tumbles more than 8% after Q2 numbers

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/divis-labs-tumbles-more-than-8-here-is-what-analysts-have-to-say/articleshow/87578556.cms

    Anand JC ECONOMICTIMES
    07 Nov 2021
    Share Share
    India's Divi's Labs hits record high Merck's +VE trial data for COVID-19 drug
    India's Divi's Labs hits record high Merck's +VE trial data for COVID-19 drug

    https://www.channelnewsasia.com/business/indias-divis-labs-hits-record-high-mercks-positive-trial-data-covid-19-drug-2219991

    CHANNELNEWSASIA
    02 Oct 2021
    Share Share
    Divi's Labs Q1 total income stood at Rs. 1.997 crore
    Divi's Labs Q1 total income stood at Rs. 1.997 crore

    http://www.pharmabiz.com/NewsDetails.aspx?aid=140670&sid=2

    PHARMABIZ
    09 Aug 2021
    Share Share
    Lack of valuation comfort may limit gains in Divi's Laboratories stock
    Lack of valuation comfort may limit gains in Divi's Laboratories stock

    https://www.business-standard.com/article/companies/lack-of-valuation-comfort-may-limit-gains-in-divi-s-laboratories-stock-121080901776_1.html

    BUSINESS-STANDARD
    09 Aug 2021
    Share Share
    Pharma shares in focus; Alkem, Divi's Lab, Syngene hit record highs
    Pharma shares in focus; Alkem, Divi's Lab, Syngene hit record highs

    https://www.business-standard.com/article/markets/pharma-shares-in-focus-alkem-divis-lab-syngene-hit-record-highs-121071600257_1.html

    BUSINESS STANDARD
    15 Jul 2021
    Share Share
    Divi's Lab, Aurobindo Pharma: Are pharma stocks losing their sheen? Read on
    Divi's Lab, Aurobindo Pharma: Are pharma stocks losing their sheen? Read on

    https://www.business-standard.com/article/markets/should-you-reshuffle-your-pharma-portfolio-as-covid-19-vaccine-gets-closer-120111100671_1.html

    Avdhut Bagkar BUSINESS-STANDARD
    10 Nov 2020
    Share Share
    Divi’s Labs posts strong performance; capex investment may boost bottomline
    Divi’s Labs posts strong performance; capex investment may boost bottomline

    http://www.pharmabiz.com/NewsDetails.aspx?aid=131084&sid=1

    PHARMABIZ
    15 Sep 2020
    Share Share
    Divi's Laboratories, SBI Life Insurance shares gain on Nifty inclusion
    Divi's Laboratories, SBI Life Insurance shares gain on Nifty inclusion

    https://www.business-standard.com/article/markets/divi-s-laboratories-sbi-life-insurance-shares-gain-on-nifty-inclusion-120082200034_1.html

    Samie Modak BUSINESS-STANDARD
    21 Aug 2020
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    polpharma-m-2024-04-15

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search